 Primary efficacy assessment will be the subjects assessments of successful and satisfactory sexual encounters as recorded in a diary question 10 in the Female Sexual Encounter Profile FSEP. Secondary evaluations of efficacy will include the other FSEP questions, a subject self-assessment questionnaire Female Sexual Function Index FSFI, two global assessment questions, a treatment satisfaction questionnaire WITS, the Beck Depression Inventory, the Dyadic Adjustment Scale DAS, a consumer testing survey QualiLife Consumer Testing Survey QCTS, and a distress scale Female Sexual Distress Scale FSDS, sexual encounter frequency, and drop-out rates. 